TORCH — Protecting Baby’s Health from the Very Beginning

Understanding the Importance of TORCH Screening

TORCH refers to a group of infectious diseases that pose significant risks during pregnancy, potentially leading to severe complications such as miscarriage, stillbirth, congenital defects, or developmental disorders. Early and accurate screening is essential to protect both maternal and fetal health.

The TORCH acronym stands for:

• T – Toxoplasmosis (TOXO): Caused by Toxoplasma gondii, this parasitic infection can lead to fetal neurological damage if contracted during pregnancy.

• O – Other Infections: Includes syphilis, varicella-zoster virus (chickenpox), and parvovirus B19—all of which can endanger fetal development.

• R – Rubella Virus (RV): Rubella infection during early pregnancy can cause Congenital Rubella Syndrome (CRS), leading to heart defects, deafness, and developmental delays.

• C – Cytomegalovirus (CMV): The most common congenital viral infection, CMV can result in hearing loss, visual impairment, or intellectual disability.

• H – Herpes Simplex Virus (HSV-1 & HSV-2): Often transmitted during delivery, neonatal herpes can be life-threatening if not detected and treated early.

Routine TORCH screening enables early intervention, minimizing the risk of maternal-fetal transmission and safeguarding the next generation from preventable harm.

Our Product Portfolio & Clinical Value

Clinical Evidence Confirms: Standardized TORCH screening with timely intervention significantly reduces the risk of congenital infections.

• RV-IgG: Confirms immunity to Rubella → Helps prevent CRS

• HSV-1/2 IgM: Detects acute infection → Helps reduce neonatal herpes risk

• HSV-1/2 IgG: Identifies past infections → Guides maternal care strategies

We are committed to advancing maternal and infant health with a line of rapid, accurate, and convenient TORCH-related test kits:

1. RV-IgG 

This test determines whether a woman has immunity to rubella—through past infection or vaccination. Immunity is vital for women of childbearing age, as rubella during early pregnancy can cause irreversible harm to the fetus. Early detection allows for vaccination planning and helps prevent CRS.

2. HSV-1-IgG / HSV-1-IgM 

• HSV-1-IgG identifies past infections, helping determine previous exposure.

• HSV-1-IgM detects current or recent infections, which are especially concerning in pregnancy due to higher transmission risk to the fetus.

Together, these tests offer clinicians comprehensive insight into infection history and risk, enabling appropriate monitoring and intervention.

3. HSV-2-IgG / HSV-2-IgM

• HSV-2-IgG confirms previous HSV-2 exposure, which helps assess long-term maternal immunity or infection risk.

• HSV-2-IgM detects acute infection, crucial for timely treatment and reducing the risk of vertical transmission and neonatal herpes.

Accurate and early detection plays a critical role in planning for safe delivery and the use of antiviral therapy when needed.

Why Choose Our TORCH Test Kits?

• CE Certified: Internationally recognized for quality and safety

• Rapid Results: Point-of-care testing delivers results in just 15 minutes

• High Accuracy: Strong correlation with CLIA methods

• Cost-Efficient: One cassette per test with no hidden costs

• Fully Automatic: Internal calibration—no manual input required

• User-Friendly: Touchscreen interface and built-in thermal printer for easy operation

The Benefits of Integrating TORCH Testing into Prenatal Care:

✔ Early identification of high-risk pregnancies
✔ Informed preventive or therapeutic decision-making
✔ Reduced rates of congenital infections and complications

Early diagnosis saves lives. With our advanced diagnostic solutions—RV-IgG, HSV-1-IgG, HSV-1-IgM, HSV-2-IgG, and HSV-2-IgM—we help healthcare professionals protect maternal and infant health with confidence and precision.